Thierry Lecomte Selected Research

Aerosols

1/2022	Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer.
9/2021	Pressurized Intraperitoneal Aerosol Chemotherapy for Colorectal Peritoneal Metastases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Thierry Lecomte Research Topics

Disease

61	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 08/2002
41	Neoplasms (Cancer) 01/2024 - 08/2002
18	Adenocarcinoma 01/2024 - 12/2014
13	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2005
9	Pancreatic Neoplasms (Pancreatic Cancer) 11/2022 - 06/2002
6	Colonic Neoplasms (Colon Cancer) 02/2024 - 12/2009
6	Neutropenia 01/2024 - 01/2010
6	Rectal Neoplasms (Rectal Cancer) 04/2022 - 08/2019
5	Microsatellite Instability 05/2022 - 07/2016
5	Crohn Disease (Crohn's Disease) 01/2022 - 11/2003
5	Stomach Neoplasms (Stomach Cancer) 01/2022 - 04/2016
3	Thrombocytopenia (Thrombopenia) 01/2024 - 01/2017
3	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2024 - 02/2021
3	COVID-19 02/2023 - 01/2020
3	Disease Progression 01/2022 - 10/2011
3	Hepatocellular Carcinoma (Hepatoma) 03/2021 - 12/2008
2	Asthenia 01/2024 - 03/2021
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2022 - 09/2015
2	Ankylosing Spondylitis 01/2022 - 10/2016
2	Rheumatoid Arthritis 01/2022 - 10/2016
2	Neuroendocrine Carcinoma 06/2020 - 10/2015
2	Mucositis 12/2019 - 01/2017
2	Fatigue 12/2019 - 01/2017
2	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2019 - 02/2015
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 05/2006 - 04/2005
1	Anemia 01/2024
1	Adenosquamous Carcinoma 01/2023
1	Frailty 01/2022
1	Cachexia 01/2022
1	Necrosis 01/2022
1	Primitive Neuroectodermal Tumors (PNET) 01/2022
1	Sarcopenia 11/2021
1	Esophageal Stenosis (Esophageal Stricture) 09/2021
1	Liver Failure 03/2021

Drug/Important Bio-Agent (IBA)

13	Fluorouracil (Carac)FDA LinkGeneric 01/2024 - 06/2002
12	Gemcitabine FDA Link 01/2024 - 06/2002
12	Monoclonal AntibodiesIBA 01/2022 - 10/2009
10	Bevacizumab (Avastin)FDA Link 12/2023 - 12/2008
10	Cetuximab (Erbitux)FDA Link 01/2023 - 09/2008
9	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 01/2010
7	Biomarkers (Surrogate Marker)IBA 01/2023 - 03/2015
7	Leucovorin (Folinic Acid)FDA Link 12/2020 - 06/2002
6	ErbB Receptors (EGF Receptor)IBA 01/2023 - 10/2009
6	folfirinoxIBA 11/2022 - 09/2015
5	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2024 - 05/2006
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2013
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023 - 11/2016
4	CalciumIBA 05/2022 - 06/2016
4	130-nm albumin-bound paclitaxelIBA 09/2019 - 09/2015
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 03/2021
3	Carcinoembryonic AntigenIBA 12/2023 - 11/2016
3	afliberceptIBA 12/2022 - 01/2020
3	Immune Checkpoint InhibitorsIBA 04/2022 - 01/2021
3	RamucirumabIBA 01/2022 - 01/2018
3	Infliximab (Remicade)FDA Link 01/2022 - 12/2015
3	Sunitinib (Sutent)FDA Link 01/2022 - 12/2008
3	Circulating Tumor DNAIBA 12/2021 - 07/2019
3	PlatinumIBA 06/2020 - 09/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2024 - 01/2022
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 08/2002
2	Calcibiotic Root Canal SealerIBA 04/2022 - 08/2017
2	Calcium Channels (Calcium Channel)IBA 01/2022 - 04/2019
2	Everolimus FDA Link 01/2022 - 12/2019
2	AerosolsIBA 01/2022 - 09/2021
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022 - 02/2021
2	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2002
2	Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA 01/2022 - 04/2019
2	BilirubinIBA 03/2021 - 12/2014
2	Panitumumab (Vectibix)FDA Link 01/2021 - 02/2018
2	Angiopoietin-2IBA 10/2020 - 03/2015
2	eryaspaseIBA 05/2020 - 01/2020
2	EnzymesIBA 12/2019 - 06/2004
2	Indigo Carmine (Indigo Blue)IBA 10/2019 - 02/2015
2	Matrix Metalloproteinases (MMPs)IBA 04/2005 - 01/2005
1	spleen fibrinolytic proteinase (human) (SFP)IBA 02/2024
1	Radioisotopes (Radionuclides)IBA 01/2024
1	lutetium Lu 177 dotatateIBA 01/2024
1	Peptide Receptors (Peptide Receptor)IBA 01/2024
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2024
1	A-factor (Streptomyces)IBA 01/2024
1	Immunoglobulins (Immunoglobulin)IBA 01/2023
1	CurcuminIBA 05/2022
1	encorafenibIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	PotassiumIBA 01/2022
1	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 01/2022
1	UbiquitinIBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	pembrolizumabIBA 10/2021
1	HydrogelsIBA 09/2021

Therapy/Procedure

39	Drug Therapy (Chemotherapy) 01/2024 - 09/2004
22	Therapeutics 01/2024 - 06/2002
4	Neoadjuvant Therapy 04/2022 - 06/2020
3	Adjuvant Chemotherapy 01/2023 - 07/2016
3	Chemoradiotherapy 01/2021 - 10/2015
2	Continuity of Patient Care 02/2023 - 12/2022
2	Microbubbles 01/2022 - 01/2019
1	Immunotherapy 04/2022
1	Enhanced Recovery After Surgery 01/2022
1	Aftercare (After-Treatment) 01/2022